Have a personal or library account? Click to login
HLA DQA1* and HLA-DQB1* alleles and genetic susceptibility to autoimmune thyroiditis in Down syndrome children: An Indonesian study Cover

HLA DQA1* and HLA-DQB1* alleles and genetic susceptibility to autoimmune thyroiditis in Down syndrome children: An Indonesian study

Open Access
|Sep 2025

References

  1. Ayme S, Mercier P, Dallest R, Mattei JF. HLA and trisomy 21. Confirmation of a trend of restricted HLA heterogeneity in parents of Down syndrome children. Am J Human Genet 36, 405–412, 1984.
  2. Bogner U, Badenhoop K, Peters H, Schmieg D, Mayr WR, Usadel KH, Schleusener H. HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity 14, 155–158, 1992.
  3. Boguslawska J, Godlewska M, Gajda E, Piekielko-Witkowska A. Cellular and molecular basis of thyroid autoimmunity. Eur Thyroid J 11, e210024, 2022.
  4. Chen PL, Fann CSJ, Chu CC, Chang CC, Chang SW, Hsieh HY, Lin M, Yang WS, Chang TC. Comprehensive geno-typing in two homogeneous Graves’ disease samples reveals major and novel HLA association alleles. PLoS ONE 6, e16635, 2011.
  5. Cho WK, Jung MH, Choi EJ, Choi HB, Kim TG, Suh BK. Association of HLA alleles with autoimmune thyroid disease in Korean children. Horm Res Paediatr 76, 328–334, 2011.
  6. Davies TF, Latif R, Yin X. New genetic insights from autoimmune thyroid disease. J Thyroid Res 2012, 623852, 2012.
  7. Faizi M, Rochmah N, Hisbiyah Y, Perwitasari RK, Putri QAN, Basuki S, Endaryanto A, Soetjipto S. Cytotoxic T-lymphocyte-associated protein 4 +49A/G polymorphism in Down syndrome children with Hashimoto’s thyroiditis. Biomol Biomed 23, 634–639, 2023a.
  8. Faizi M, Rochmah N, Soetjipto S, Endaryanto A, Basuki S, Hisbiyah Y, Perwitasari RK. Protein tyrosine phosphatase non-receptor type 22 C1858T gene polymorphism in children with down syndrome and autoimmune thyroid diseases. Pediatr Med Chir 45, 2023b.
  9. Ferrari M, Stagi S. Autoimmunity and genetic syndromes: A focus on down syndrome. Genes 12, 268, 2021.
  10. Giza S, Galli-Tsinopoulou A, Lazidou P, Trachana M, Goulis D. HLA-DQB1*05 association with Hashimoto’s thyroiditis in children of Northern Greek origin. Indian Pediatr 45, 493–496, 2008.
  11. Ikegami H, Kawaguchi Y, Yamato E, Kuwata S, Tokunaga K, Noma Y, Shima K, Ogihara T. Analysis by the polymerase chain reaction of histocompatibility leucocyte antigen-DR9-linked susceptibility to insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 75, 1381–1385, 1992.
  12. Jang HW, Shin HW, Cho HJ, Kim HK, Lee JI, Kim SW, Kim JW, Chung JH. Identification of HLA-DRB1 alleles associated with Graves’ disease in Koreans by sequence-based typing. Immunol Invest 40, 172–182, 2011.
  13. Kacem HH, Rebai A, Ayadi H, Farid NR. The genetics of autoimmune thyroid disease. J Endocr Genet 3, 115–128, 2003.
  14. Kazemi M, Salehi M, Kheirollahi, M. Down syndrome: current status, shallenges and future perspectives. Int J Mol Cell Med 5, 125–133, 2016.
  15. Kelly MA, Rayner ML, Mijovic CH, Barnett AH. Molecular aspects of type 1 diabetes. J Clin Pathol Mol Pathol 56, 1–10, 2003.
  16. Kyritsi EM, Kanaka-Gantenbein C. Autoimmune Thyroid Disease in Specific Genetic Syndromes in Childhood and Adolescence. Front Endocrinol 11, 543, 2020.
  17. Larizza D, Calcaterra V, Martinetti M, Negrini R, De Silvestri A, Cisternino M, Iannone AM, Solcia E. Helicobacter pylori infection and autoimmune thyroid disease in young patients: the disadvantage of carrying the human leukocyte antigen- DRB1*0301 allele. J Clin Endocrinol Metab 91, 176–179, 2006.
  18. Marcovecchio GE, Bortolomai I, Ferrua F, Fontana E, Imberti L, Conforti E, Amodio D, Bergante S, Macchiarulo G, D’Oria V, Conti F, Cesare S, Di, Fousteri G, Carotti A, Giamberti A, Poliani PL, Notarangelo LD, Cancrini C, Villa A, Bosticardo M. Thymic epithelium abnormalities in DiGeorge and Down syndrome patients contribute to dysregulation in T cell development. Front Immunol 10, 447, 2019.
  19. Matsushita S, Takahashi K, Motoki M, Komoriya K, Ikagawa S, Nishimura Y. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: Implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 180, 873–883, 1994.
  20. Matzaraki V, Kumar V, Wijmenga C, Zhernakova A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol 18, 76, 2017.
  21. Miyadera H, Ohashi J, Lernmark A, Kitamura T, Tokunaga K. Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA. J Clin Invest 125, 275–291, 2015.
  22. Mottironi VD, Hook EB, Willey AM, Porter IH, Swift RV, Hatcher NH. Decreased HLA heterogeneity in parents of children with Down syndrome. Am J Human Genetics 35, 1289, 1983.
  23. Myoung HP, Young JP, Eun YS, Park H, Tae YK, Do JP, Kyong SP, Bo YC. Association of HLA-DR and -DQ genes with Graves disease in Koreans. Hum Immunol 66, 741–747, 2005.
  24. Nicholson LB, Wong FS, Ewins DL, Butler J, Holland A, Demaine AG, McGregor AM. Susceptibility to autoimmune thyroiditis in Down’s syndrome is associated with the major histocompatibility class II DQA 0301 allele. Clin Endocrinol 41, 381–383, 1994.
  25. Okada Y, Momozawa Y, Ashikawa K, Kanai M, Matsuda K, Kamatani Y, Takahashi A, Kubo M. Construction of a population-specific HLA imputation reference panel and its application to Graves’ disease risk in Japanese. Nat Genet 47, 798–802, 2015.
  26. Onuma H, Ota M, Sugenoya A, Inoko H. Association of HLA-DPB1 *0501 with early-onset Graves’ disease in Japanese. Human Immunology 39, 195–201, 1994.
  27. Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Di Mario U, Buzzetti R. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto’s thyroiditis in an Italian population. Thyroid 11, 171–175, 2001.
  28. Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 164, 9–16, 2011.
  29. Ramgopal S, Rathika C, Padma Malini R, Murali V, Arun K, Balakrishnan K. Critical amino acid variations in HLADQB1* molecules confers susceptibility to Autoimmune Thyroid Disease in south India. Genes Immun 20, 32–38, 2019.
  30. Satge D, Seidel MG. The pattern of malignancies in down syndrome and its potential context with the immune system. Front Immunol 9, 3058, 2018.
  31. Shin DH, Baek IC, Kim HJ, Choi EJ, Ahn M, Jung MH, Suh BK, Cho WK, Kim TG. HLA alleles, especially amino-acid signatures of HLA-DPB1, might contribute to the molecular pathogenesis of early-onset autoimmune thyroid disease. PLoS One 14, e0216941, 2019.
  32. Soetjipto, Rochmah N, Faizi M, Hisbiyah, Y, Endaryanto A. HLA-DQA1 and HLA-DQB1 gene polymorphism in Indonesian children with type I diabetes mellitus. Appl Clin Genetics 15, 11–17, 2022.
  33. Stoll C, Alembik Y, Armbruster N, Tongio M, Mayer S. HLA and Down syndrome (DS): parents at the origin of the nondisjunction share no more HLA-A and -B antigens with their DS child than controls. Genet Epidemiol 5, 235–240, 1988.
  34. Sullivan KD, Evans D, Pandey A, Hraha TH, Smith KP, Markham N, Rachubinski AL, Wolter-Warmerdam K, Hickey F, Espinosa JM, Blumenthal T. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep 7, 14818, 2017.
  35. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24, 694–717, 2003.
  36. Ueda S, Oryoji D, Yamamoto K, Noh JY, Okamura K, Noda M, Kashiwase K, Kosuga Y, Sekiya K, Inoue K, Yamada H, Oyamada A, Nishimura Y, Yoshikai Y, Ito K, Sasazuki T. Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J Clin Endocrinol Metab 99, E379–E383, 2014.
  37. Verstegen RHJ, Driessen GJ, Bartol SJW, Van Noesel CJM, Boon L, Van Der Burg M, Van Dongen JJM, De Vries E, Van Zelm MC. Defective B-cell memory in patients with Down syndrome. J Allergy Clin Immunol 134, 1346–1353.e9, 2014.
  38. Wei L, Zhao N, Li Y, Zheng X, Zhang H, Zhang Z. Down syndrome with primary thyroid diffuse large B-cell lymphoma and Hashimoto thyroiditis: A CARE compliant case report. Medicine 98, e16994, 2019.
  39. Wong GWK, Cheng SH, Dorman JS. The HLA-DQ associations with Graves’ disease in Chinese children. Clin Endocrinol 50, 493–495, 1999.
  40. Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, Ahmed AR, Strominger JL. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Nat Acad Sci USA 92, 11935, 1995.
  41. Yanagawa T, Mangklabruks A, DeGroot LJ. Strong association between HLA-DQA1*0501 and Graves’ disease in a male Caucasian population. J Clin Endocrinol Metab 79, 227–229, 1994.
  42. Zeitlin AA, Heward JM, Newby PR, Carr-Smith JD, Franklyn JA, Gough SCL, Simmonds MJ. Analysis of HLA class II genes in Hashimoto’s thyroiditis reveals differences compared to Graves’ disease. Genes Immun 9, 358–363, 2008.
DOI: https://doi.org/10.2478/enr-2025-0010 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Language: English
Page range: 87 - 94
Published on: Sep 5, 2025
Published by: Slovak Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year

© 2025 Yuni Hisbiyah, Anang Endaryanto, Bagus Setyoboedi, Nur Rochmah, Muhammad Faizi, Sukmawati Basuki, Asri Maharani, published by Slovak Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.